HybO2 has been treating Long COVID sufferers with significant results. This is backed up by a detailed scientific randomised controlled trial on the improvements HBOT has on neurocognitive functions and symptoms of post-COVID conditions.
HybO2 has been treating Long COVID sufferers with significant results. This is backed up by a detailed scientific randomised controlled trial on the improvements Hyperbaric Oxygen Therapy (HBOT) has on neurocognitive functions and symptoms of post-COVID conditions.
Authors: Shani Zilberman‑Itskovich, Merav Catalogna1,4, Efrat Sasson1, Karin Elman‑Shina, Amir Hadanny, Erez Lang, Shachar Finci1, Nir Polak, Gregory Fishlev, Calanit Korin, Ran Shorer, Yoav Parag, Marina Sova1 & Shai Efrati1.
